Inclusion and exclusion criteria decided by the steering group to determine patient eligibility for CATALYST
| Inclusion . | Exclusion . |
|---|---|
| Age ≥ 18 years Labelled as penicillin allergic Currently on or requiring antibiotic therapy Capacity/ability to consent (e.g. no cognitive impairment) Inpatient | Regular antihistamine Regular immunosuppressant medication, including but not limited to: systemic anticancer treatments (SACT); disease-modifying anti-rheumatoid drugs (DMARDS); biologics Taking corticosteroids at any dose (excluding topical and low-dose inhaled, e.g. beclomethasone 1000 μg/day or fluticasone 500 μg/day or equivalent). Note: must be 24 h clear of stat doses of corticosteroids, e.g. intra-operatively Receiving inotropic support Planning pregnancy or currently pregnant or breastfeeding History of poorly controlled asthma Clinical signs of severe allergy:
|
| Inclusion . | Exclusion . |
|---|---|
| Age ≥ 18 years Labelled as penicillin allergic Currently on or requiring antibiotic therapy Capacity/ability to consent (e.g. no cognitive impairment) Inpatient | Regular antihistamine Regular immunosuppressant medication, including but not limited to: systemic anticancer treatments (SACT); disease-modifying anti-rheumatoid drugs (DMARDS); biologics Taking corticosteroids at any dose (excluding topical and low-dose inhaled, e.g. beclomethasone 1000 μg/day or fluticasone 500 μg/day or equivalent). Note: must be 24 h clear of stat doses of corticosteroids, e.g. intra-operatively Receiving inotropic support Planning pregnancy or currently pregnant or breastfeeding History of poorly controlled asthma Clinical signs of severe allergy:
|
Inclusion and exclusion criteria decided by the steering group to determine patient eligibility for CATALYST
| Inclusion . | Exclusion . |
|---|---|
| Age ≥ 18 years Labelled as penicillin allergic Currently on or requiring antibiotic therapy Capacity/ability to consent (e.g. no cognitive impairment) Inpatient | Regular antihistamine Regular immunosuppressant medication, including but not limited to: systemic anticancer treatments (SACT); disease-modifying anti-rheumatoid drugs (DMARDS); biologics Taking corticosteroids at any dose (excluding topical and low-dose inhaled, e.g. beclomethasone 1000 μg/day or fluticasone 500 μg/day or equivalent). Note: must be 24 h clear of stat doses of corticosteroids, e.g. intra-operatively Receiving inotropic support Planning pregnancy or currently pregnant or breastfeeding History of poorly controlled asthma Clinical signs of severe allergy:
|
| Inclusion . | Exclusion . |
|---|---|
| Age ≥ 18 years Labelled as penicillin allergic Currently on or requiring antibiotic therapy Capacity/ability to consent (e.g. no cognitive impairment) Inpatient | Regular antihistamine Regular immunosuppressant medication, including but not limited to: systemic anticancer treatments (SACT); disease-modifying anti-rheumatoid drugs (DMARDS); biologics Taking corticosteroids at any dose (excluding topical and low-dose inhaled, e.g. beclomethasone 1000 μg/day or fluticasone 500 μg/day or equivalent). Note: must be 24 h clear of stat doses of corticosteroids, e.g. intra-operatively Receiving inotropic support Planning pregnancy or currently pregnant or breastfeeding History of poorly controlled asthma Clinical signs of severe allergy:
|
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
